SCHEMBL201039

SCHEMBL201039

C1=CCc2ccccc2OC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OXTR P30559 1/20 0.42
MAOA P21397 2/20 0.39
MAOB P27338 2/20 0.39
ABCG2 Q9UNQ0 1/20 0.39
ITGB2 P05107 1/20 0.39
ICAM1 P05362 1/20 0.39
ITGAL P20701 1/20 0.39
TSHR P16473 2/20 0.35
LMNA P02545 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
CRHBP P24387 2/20 0.34
CRHR2 Q13324 2/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
GAA P10253 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HTR2C P28335 1/20 0.31
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21428192 0.87 OXTR (0.39) OXTRMAOAMAOBABCG2ITGB2
SCHEMBL7509076 0.80 ABCG2 (0.58) OXTRMAOAMAOBABCG2ITGB2
SCHEMBL7509071 0.80 ABCG2 (0.58) OXTRMAOAMAOBABCG2ITGB2
SCHEMBL135424 0.79 OXTR (0.43) OXTRMAOAMAOBABCG2ITGB2
SCHEMBL18685784 0.75 TSHR (0.44) OXTRMAOAMAOBABCG2ITGB2
SCHEMBL20081628 0.75 OXTR (0.34) OXTRMAOAMAOBABCG2ITGB2
SCHEMBL25135417 0.73 PKM (0.48) MAOAMAOBABCG2ITGB2ICAM1
SCHEMBL44447 0.71 TSHR (0.44) MAOAMAOBTSHRHTR2C
SCHEMBL29507678 0.71 TSHR (0.44) MAOAMAOBTSHRHTR2C
SCHEMBL7197365 0.70 MAOA (0.41) OXTRMAOAMAOBABCG2ITGB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691843-B2 N-hydroxyamide derivatives possessing antibacterial activity PFIZER INC. (US) 2010-04-06 US claimed
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity VICURON HOLDINGS LLC 2008-03-06 US claimed
US-20250154122-A1 PROCESS FOR THE PREPARATION OF COMPOUNDS COMPRISING A 2,5-DIHYDROBENZOXEPINE STRUCTURE BY PHOTOCHEMICAL REARRANGEMENT ECOLE POLYTECHNIQUE (FR) 2025-05-15 US disclosed
US-20250154122-A1 PROCESS FOR THE PREPARATION OF COMPOUNDS COMPRISING A 2,5-DIHYDROBENZOXEPINE STRUCTURE BY PHOTOCHEMICAL REARRANGEMENT ECOLE POLYTECHNIQUE (FR) 2025-05-15 US disclosed
US-20250154122-A1 PROCESS FOR THE PREPARATION OF COMPOUNDS COMPRISING A 2,5-DIHYDROBENZOXEPINE STRUCTURE BY PHOTOCHEMICAL REARRANGEMENT ECOLE POLYTECHNIQUE (FR) 2025-05-15 US disclosed
US-20250042854-A1 IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF ECOLE NAT SUPERIEURE DE CHIMIE DE RENNES (FR) 2025-02-06 US disclosed
EP-4479391-A1 PROCESS FOR THE PREPARATION OF COMPOUNDS COMPRISING A 2,5-DIHYDROBENZOXEPINE STRUCTURE BY PHOTOCHEMICAL REARRANGEMENT Ecole Polytechnique (FR) 2024-12-25 EP disclosed
CN-118984826-A Method for preparing compounds comprising 2, 5-dihydrobenzoxazepine structures by photochemical rearrangement 巴黎综合理工学院 2024-11-19 CN disclosed
US-12145927-B2 Inhibitors of indoleamine 2,3-dioxygenase and methods of their use BRISTOL-MYERS SQUIBB COMPANY (US) 2024-11-19 US disclosed
EP-4433451-A1 IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF Ecole Nationale Supérieure de Chimie de Rennes (FR) 2024-09-25 EP disclosed
WO-2023156461-A1 PROCESS FOR THE PREPARATION OF COMPOUNDS COMPRISING A 2,5-DIHYDROBENZOXEPINE STRUCTURE BY PHOTOCHEMICAL REARRANGEMENT ECOLE POLYTECHNIQUE (FR) 2023-08-24 WO disclosed
WO-2005012320-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIMICROBIAL ACTIVITY VICURON PHARMACEUTICALS, INC. (US) 2005-02-10 WO disclosed
WO-2004080217-A1 ELECTROPROCESSED PHENOLIC MATERIALS AND METHODS VIRGINIA COMMONWEATH UNIVERSITY (US) 2004-09-23 WO disclosed
WO-2004074413-A2 NEW LOW NOISE GREASE GELLING AGENTS CHEVRON U.S.A. INC. (US) 2004-09-02 WO disclosed
US-20040167045-A1 LOW NOISE GREASE GELLING AGENTS CHEVRON U.S.A., INC. 2004-08-26 US disclosed
WO-2004069964-A2 STABLE OLEFINIC, LOW SULFUR DIESEL FUELS CHEVRON U.S.A. INC. (US) 2004-08-19 WO disclosed
US-20040148850-A1 Stable olefinic, low sulfur diesel fuels SASOL TECHNOLOGY (PTY) LTD. (ZA) 2004-08-05 US disclosed
US-20040152930-A1 Stable olefinic, low sulfur diesel fuels SASOL TECHNOLOGY (PTY) LTD. (ZA) 2004-08-05 US disclosed
EP-1140893-A1 BENZOPYRANS AND BENZOXEPINES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PREPARATION PROCESS MERCK PATENT GmbH (DE) 2001-10-10 EP disclosed
WO-2000039113-A1 BENZOPYRANS AND BENZOXEPINES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2000-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250154122-A1 PROCESS FOR THE PREPARATION OF COMPOUNDS COMPRISING A 2,5-DIHYDROBENZOXEPINE STRUCTURE BY PHOTOCHEMICAL REARRANGEMENT DHPS, DDT, DHX15 OXTR 2048/4885MAOA 81/4885MAOB 30/4885
US-12145927-B2 Inhibitors of indoleamine 2,3-dioxygenase and methods of their use IDO1, IDO2, INMT OXTR 4514/4885MAOA 12/4885MAOB 11/4885
US-20250042854-A1 IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF SQLE, SYMPK, FDFT1 OXTR 350/4885MAOA 1970/4885MAOB 1609/4885
US-20080058304-A1 N-hydroxyamide derivatives possessing antibacterial activity AMDHD2, OGA, ENGASE OXTR 3853/4885MAOA 110/4885MAOB 307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.